Chemistry & Biodiversity · 2010 · 25 citations · 29 references
PharmacyMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug DiscoveryStructure-activity RelationshipsBioactive Natural ProductsEnzyme InhibitionMarine Bioactive CompoundsMarine Natural ProductsMarine PharmacologyMetabolite IdentificationBioactive Compounds From Marine SpongesBioactive Marine MetabolitesMarine Microbial Natural ProductsMarine Sponge MetabolitesMarine-derived Enzyme InhibitorsMass Spectrometric IdentificationSponges As Drug SourcesSponges-derived Metabolites
Two new brominated compounds, subereaphenol K (2) and 2-(3,5-dibromo-1-ethoxy-4-oxocyclohexa-2,5-dien-1-yl)acetamide (3), together with subereaphenol B (methyl 2-(2,4-dibromo-3,6-dihydroxyphenyl)acetate; 1) with a revised structure, and five dibromotyrosine-derived metabolites, 4-8, were isolated from the sponge Suberea sp. and characterized by 1D- and 2D-NMR spectroscopic and HR-MS spectrometric data. Compounds 1, 2, 6, and 8 exhibited various weak or moderate bioactivities, including antimicrobial and cytotoxic activities. Furthermore, compounds 1 and 2 inhibited human recombinant phosphodiesterase 4 (PDE4) with IC₅₀ values of 2 μM, whereas compounds 6 and 8 were less active.
29
A new and rapid colorimetric determination of acetylcholinesterase activity
George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology · 1961 · 26.9K citations
L A Collins, Scott G. Franzblau · Antimicrobial Agents and Chemotherapy · 1997 · 1.6K citations · Full text
Veterinary Medicine, Infectious Diseases, Antimicrobial Pharmacology +7